BeiGene Ltd. (BGNE)
BeiGene Statistics
Share Statistics
BeiGene has 109.41M shares outstanding. The number of shares has increased by -0.79% in one year.
| 109.41M |
| -0.79% |
| -1.26% |
| 43.88% |
| 57.61M |
| 986 |
| 0.28% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -21.31 and the forward PE ratio is null. BeiGene's PEG ratio is 0.38.
| -21.31 |
| n/a |
| 7.64 |
| n/a |
| 5.31 |
| -10.71 |
| 0.38 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BeiGene.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.
| 2.32 |
| 2.09 |
| 0.26 |
| -0.83 |
| -0.53 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $231,960.28 |
| $-83,180 |
| 10,600 |
| 0.42 |
| 0.91 |
Taxes
| 55.87M |
| -6.77% |
Stock Price Statistics
The stock price has increased by 28.16% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been higher than the market average.
| 0.63 |
| 28.16% |
| 194.34 |
| 182.89 |
| 77.12 |
| 357,765 |
Income Statement
In the last 12 months, BeiGene had revenue of 2.46B and earned -881.71M in profits. Earnings per share was -0.65.
| 2.46B |
| 2.08B |
| -1.21B |
| -881.71M |
| -1.12B |
| -1.21B |
| -0.65 |
Balance Sheet
The company has 3.17B in cash and 930.18M in debt, giving a net cash position of 2.24B.
| 3.17B |
| 930.18M |
| 2.24B |
| -7.96B |
| 5.83B |
| 1.89B |
Cash Flow
In the last 12 months, operating cash flow was -1.16B and capital expenditures -596.26M, giving a free cash flow of -1.75B.
| -1.16B |
| -596.26M |
| -1.75B |
| -1.29 |
Margins
Gross margin is 84.55%, with operating and profit margins of -49.12% and -35.86%.
| 84.55% |
| -49.12% |
| -33.59% |
| -35.86% |
| -45.55% |
| -49.12% |
| -71.32% |
Dividends & Yields
BGNE does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for BGNE is $288, which is 55.9% higher than the current price. The consensus rating is "Strong Buy".
| $288 |
| 55.9% |
| Strong Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 3.5 |
| 4 |